These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11783069)

  • 1. [Clinical significance of CD44 expression in ovarian epithelial tumors].
    Qu P; Jiao S; Gao Q
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):46-9. PubMed ID: 11783069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
    Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.
    Motohara T; Fujimoto K; Tayama S; Narantuya D; Sakaguchi I; Tashiro H; Katabuchi H
    Obstet Gynecol; 2016 Jun; 127(6):1003-1011. PubMed ID: 27159753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression.
    Saegusa M; Machida D; Hashimura M; Okayasu I
    J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
    Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
    Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
    Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
    Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas].
    Wang A; Lu L; Wang Y; Sun Y; Zhang Y; Guo C; Gu Y; Liu A
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):20-4. PubMed ID: 24713244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
    Gu L; Shigemasa K; Ohama K
    Int J Oncol; 2004 Mar; 24(3):671-8. PubMed ID: 14767552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.
    Sakai K; Kaku T; Kamura T; Kinukawa N; Amada S; Shigematsu T; Hirakawa T; Kobayashi H; Ariyoshi K; Nakano H
    Gynecol Oncol; 1999 Mar; 72(3):360-6. PubMed ID: 10053108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 adhesion molecules on human placentae.
    Choi CH; Roh CR; Kim TJ; Choi YL; Lee JW; Kim BG; Lee JH; Bae DS
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):243-7. PubMed ID: 16504370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.